ÂÜÀòÂÒÂ×

Darrell Irvine is an accomplished investigator at Howard Hughes Medical Institute and a professor at MIT, with extensive experience in biotechnology and academic research. Since earning a Doctor of Philosophy in Polymer Science from the Massachusetts Institute of Technology, Darrell Irvine has co-founded multiple companies, including Strand Therapeutics and Elicio Therapeutics, while also serving as a scientific advisory board member for several organizations such as Alloy Therapeutics, Mass General Cancer Center, and Medicine by Design at the University of Toronto. With a solid foundation in engineering physics from the University of Pittsburgh, Darrell Irvine has made significant contributions to the scientific community, particularly in the development of innovative therapeutic solutions.